Latest Allotransplantation Stories

--Recovery is second of its kind in Texas -- FORT WORTH, Texas, Feb. 16, 2012 /PRNewswire-USNewswire/ -- LifeGift, one of the three not-for-profit organ and tissue recovery organizations based in Texas, announced today that it has coordinated the recovery of its first hand to be used in a transplant. The donation, which took place at JPS Health Network, is the second of its kind in Texas. Referred to as vascularized composite allograft, the hand will be used to restore function...

BELGRADE, Mont., Feb. 10, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, presented at the American Academy of Orthopaedic Surgeons (AAOS) 2012 Annual Meeting in San Francisco, CA, its study showing OsteoSponge® equivalence to rhBMP-2 in spinal fusion. The study, first presented at EuroSpine 2011 in Milan, Italy in October of last year,...

SAN FRANCISCO, Feb. 8, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announces the nationwide launch of AmnioFix® Injectable, the Company's newest tissue offering. MiMedx is formally unveiling AmnioFix® Injectable today during the first day of the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting being held in...

EDISON, N.J., Jan. 18, 2012 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF), the world's leading tissue bank has announced the recipients of its 2012 Research Grants. Since 1987 the Musculoskeletal Transplant Foundation has been at the forefront of tissue research, with about $33 million awarded through 2011. MTF anticipates awarding close to $2 million in grants and awards in the 2012 calendar year. The 2012 grant recipients approved for funding are as follows:...

DENVER, Jan. 18, 2012 /PRNewswire/ -- Donor Alliance, the federally-designated, non-profit organ procurement organization and American Association of Tissue Banks (AATB) accredited tissue bank serving Colorado and Wyoming, saw another banner year in 2011, with a record number of organ donors enabling 52 more people to receive lifesaving transplants than in 2010. Additionally, the organization worked with 966 tissue donors and their families to recover lifesaving and...

Alpha-1-antitrypsin reduced intense inflammation after bone marrow transplant A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants. Researchers from the University of Michigan Comprehensive Cancer Center looked at the drug alpha-1-antitrypsin, which is approved by the U.S. Food and Drug Administration for use in people who have a genetic...

1,185 gifts of life were transplanted because of the generosity of donors and their families PHILADELPHIA, Jan. 13, 2012 /PRNewswire-USNewswire/ -- Gift of Life Donor Program - the region's organ procurement organization (OPO) serving eastern Pennsylvania, southern New Jersey and Delaware - announced that the organization coordinated the recovery of 1,185 organs from a record 441 individuals in 2011, making this region the most generous in the U.S. and setting a new national record....

Meaningful Recovery Achieved in 87 Percent of Patients with Peripheral Nerve Injury SAN FRANCISCO, Jan. 12, 2012 /PRNewswire-USNewswire/ -- In the first-ever multicenter clinical trial on processed nerve allograft, researchers from The Buncke Clinic in San Francisco found that treatment of severed peripheral nerve with processed nerve allograft showed meaningful recovery in 87 percent of patients, comparing favorably to traditional nerve repair (autograft nerve). The study...

EDISON, N.J., Jan. 4, 2012 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) has announced the release of two new sizes of its popular FLEX HD® bi-lateral breast kits. The new sizes--16cm x 20cm and 20cm x 20cm--are being introduced in order to meet the needs of surgeons and their patients. This unique human dermal allograft is specifically prepared and packaged for bilateral breast reconstruction. It has been a year since MTF introduced its bi-lateral breast...

HORSHOLM, Denmark, Jan. 4, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in the STRATO (Switching kidney TRAnsplant patients with Tremor to LCP-tacrO) Phase IIIb study of LCP-Tacro(TM) in kidney transplant recipients experiencing drug-induced tremors. The STRATO study is designed to explore whether a conversion of patients who have symptomatic tremor from treatment with standard immediate release twice-daily tacrolimus...